Hey {{first_name}} ,
A quick note on where this newsletter is headed.
Over the past year, you've been getting weekly breakdowns on AI in healthcare - studies, deployments, fraud cases, startup funding patterns, policy shifts.
The reception has been strong. The feedback has been clear: you want evidence-based analysis that cuts through hype and tells you what actually matters.
Here's what I've noticed: some of the most engaged responses haven't been about AI at all.
When I wrote about semaglutide for alcohol use disorder, psychiatrists and addiction specialists showed up.
When I covered psychiatric medications and suicide risk, the conversation expanded beyond the AI healthcare audience.
When I analyzed evidence on trauma, ADHD, or mental health interventions, a different set of readers engaged - but with the same expectation: rigorous evaluation, clinical grounding, no fluff.
So here's the evolution:
This newsletter isn't changing topics. It's broadening scope.
I evaluate evidence. Whether that's an AI study, a psychiatry RCT, a policy shift, or a clinical innovation that affects how we deliver care.
The through-line has always been the same: physician-scientist perspective, evidence-based analysis, bridging innovation and clinical reality.
AI in healthcare will remain the primary focus - probably 70-80% of editions. But you'll also see:
Evidence-based psychiatry (medications, interventions, outcomes)
Clinical research across specialties that shifts practice
Healthcare systems design and policy
Occasionally: founder lessons, scaling a telepsychiatry company, building in healthcare
The standard stays the same: No invented statistics. No fabricated claims. Everything traced to published evidence or disclosed as clinical judgment.
Why now?
Two books coming this year:
Trauma Transformed (psychiatry, neuroscience, clinical practice)
The Future of AI in Healthcare (Springer Nature)
And I'm building Sage - a telepsychiatry company designed to solve access and quality gaps in mental healthcare.
It doesn't make sense to separate these into different voices. They're not separate. They're one integrated practice.
So what changes for you?
The newsletter format you've been seeing - small paragraphs, evidence-first, visual suggestions, no BS - stays exactly the same.
The topics broaden slightly to match what I'm already writing about on LinkedIn.
The standard for rigor stays identical.
What doesn't change:
Weekly cadence
Evidence-based analysis
Same voice, same format
Same commitment: tell you what matters, skip the hype
If you signed up for AI healthcare insights, you'll keep getting them - just with occasional detours into adjacent territory where the same evaluation framework applies.
If that sounds good, you're already subscribed. Nothing to do.
If you'd rather stick to pure AI healthcare content, I understand - unsubscribe link is below, no hard feelings.
Either way, thanks for reading.
Talk soon,
Bhargav
Follow me: LinkedIn
P.S. I'm currently writing Trauma Transformed - a book on the neuroscience and clinical treatment of trauma. Every few editions, I'll share behind-the-scenes updates on the research and writing process.